Results 111 to 120 of about 20,481 (152)
Colistin Resistance Mechanisms and Molecular Epidemiology of Enterobacter cloacae Complex Isolated from a Tertiary Hospital in Shandong, China [PDF]
Zaifeng Si,1,2,* Shengmei Zhao,3,* Yingying Hao,3 Qian Wang,3 Yanfa Zhong,2 Yue Liu,3 Ran Chen,3 Yan Jin,3 Zhiming Lu1,3 1Department of Clinical Laboratory, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan ...
Liu Y +8 more
core
Serum bactericidal activity of colistin against Acinetobacter baumannii in patients with normal versus impaired renal function [PDF]
Wojno, Justyna Maria
core
Some of the next articles are maybe not open access.
Related searches:
Related searches:
JAMA, 1963
COLISTIN, a polypeptide antibiotic closely related to polymyxin B, has been in use in the United States for approximately three years. Despite the accumulation of considerable clinical experience with this agent, it is still subject to a good deal of controversy.
R G, PETERSDORF, J J, PLORDE
openaire +2 more sources
COLISTIN, a polypeptide antibiotic closely related to polymyxin B, has been in use in the United States for approximately three years. Despite the accumulation of considerable clinical experience with this agent, it is still subject to a good deal of controversy.
R G, PETERSDORF, J J, PLORDE
openaire +2 more sources
Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae [PDF]
Colistin is among the few antibiotics effective against multidrug-resistant Acinetobacter baumannii and Klebsiella pneumoniae clinical isolates. However, in the last few years, colistin-resistant A. baumannii and K.
Manuel E Jiménez-Mejias +2 more
exaly +2 more sources
OBJECTIVES: The aim of this study was to confirm the synergistic effect of colistin/rifampicin combination therapy compared with colistin monotherapy in pneumonia caused by colistin-resistant Acinetobacter baumannii (CoRAB).
Seok Hoon Jeong +2 more
exaly +2 more sources

